Li QR - Search Results

1

A Dihydroartemisinin-Loaded Nanoreactor Motivates Anti-Cancer Immunotherapy by Synergy-Induced Ferroptosis to Activate Cgas/STING for Reprogramming of Macrophage.

Li LG, Yang XX, Xu HZ, Yu TT, Li QR, Hu J, Peng XC, Han N, Xu X, Chen NN, Chen X, Tang JM, Li TF. Li LG, et al. Among authors: li qr, li tf. Adv Healthc Mater. 2023 Nov;12(28):e2301561. doi: 10.1002/adhm.202301561. Epub 2023 Aug 23. Adv Healthc Mater. 2023. PMID: 37567571

2

A nanoreactor boosts chemodynamic therapy and ferroptosis for synergistic cancer therapy using molecular amplifier dihydroartemisinin.

Yang XX, Xu X, Wang MF, Xu HZ, Peng XC, Han N, Yu TT, Li LG, Li QR, Chen X, Wen Y, Li TF. Yang XX, et al. Among authors: li qr, li tf, li lg. J Nanobiotechnology. 2022 May 14;20(1):230. doi: 10.1186/s12951-022-01455-0. J Nanobiotechnology. 2022. PMID: 35568865 Free PMC article.

3

Dihydroartemisinin remodels macrophage into an M1 phenotype via ferroptosis-mediated DNA damage.

Li LG, Peng XC, Yu TT, Xu HZ, Han N, Yang XX, Li QR, Hu J, Liu B, Yang ZY, Xu X, Chen X, Wang MF, Li TF. Li LG, et al. Among authors: li qr, li tf. Front Pharmacol. 2022 Aug 11;13:949835. doi: 10.3389/fphar.2022.949835. eCollection 2022. Front Pharmacol. 2022. PMID: 36034842 Free PMC article.

4

Dihydroartemisinin elicits immunogenic death through ferroptosis-triggered ER stress and DNA damage for lung cancer immunotherapy.

Han N, Yang ZY, Xie ZX, Xu HZ, Yu TT, Li QR, Li LG, Peng XC, Yang XX, Hu J, Xu X, Chen X, Wang MF, Li TF. Han N, et al. Among authors: li qr, li tf, li lg. Phytomedicine. 2023 Apr;112:154682. doi: 10.1016/j.phymed.2023.154682. Epub 2023 Jan 31. Phytomedicine. 2023. PMID: 36739636

5

Efficient Delivery of Chlorin e6 by Polyglycerol-Coated Iron Oxide Nanoparticles with Conjugated Doxorubicin for Enhanced Photodynamic Therapy of Melanoma.

Li TF, Xu HZ, Xu YH, Yu TT, Tang JM, Li K, Wang C, Peng XC, Li QR, Sang XY, Zheng MY, Liu Y, Zhao L, Chen X. Li TF, et al. Among authors: li qr, li k. Mol Pharm. 2021 Sep 6;18(9):3601-3615. doi: 10.1021/acs.molpharmaceut.1c00510. Epub 2021 Aug 13. Mol Pharm. 2021. PMID: 34388342

6

Macrophages mediated delivery of chlorin e6 and treatment of lung cancer by photodynamic reprogramming.

Yu TT, Sang XY, Han N, Peng XC, Li QR, Xu X, Xiao RC, Xu HZ, Chen X, Wang MF, Li TF. Yu TT, et al. Among authors: li qr, li tf. Int Immunopharmacol. 2021 Nov;100:108164. doi: 10.1016/j.intimp.2021.108164. Epub 2021 Sep 22. Int Immunopharmacol. 2021. PMID: 34562845

7

Chlorin e6 mediated photodynamic therapy triggers resistance through ATM-related DNA damage response in lung cancer cells.

Ma QL, Shen MO, Han N, Xu HZ, Peng XC, Li QR, Yu TT, Li LG, Xu X, Liu B, Chen X, Wang MF, Li TF. Ma QL, et al. Among authors: li qr, li tf, li lg. Photodiagnosis Photodyn Ther. 2022 Mar;37:102645. doi: 10.1016/j.pdpdt.2021.102645. Epub 2021 Nov 23. Photodiagnosis Photodyn Ther. 2022. PMID: 34823034

8

Harnessing chlorin e6 loaded by functionalized iron oxide nanoparticles linked with glucose for target photodynamic therapy and improving of the immunogenicity of lung cancer.

Yu TT, Peng XC, Wang MF, Han N, Xu HZ, Li QR, Li LG, Xu X, Ma QL, Liu B, Wang J, Zhao L, Chen X, Li TF. Yu TT, et al. Among authors: li qr, li tf, li lg. J Cancer Res Clin Oncol. 2022 Apr;148(4):867-879. doi: 10.1007/s00432-021-03879-x. Epub 2022 Jan 8. J Cancer Res Clin Oncol. 2022. PMID: 34997349

9

Ferroptosis triggered by dihydroartemisinin facilitates chlorin e6 induced photodynamic therapy against lung cancerthrough inhibiting GPX4 and enhancing ROS.

Han N, Li LG, Peng XC, Ma QL, Yang ZY, Wang XY, Li J, Li QR, Yu TT, Xu HZ, Xu X, Chen X, Wang MF, Li TF. Han N, et al. Among authors: li j, li qr, li tf, li lg. Eur J Pharmacol. 2022 Mar 15;919:174797. doi: 10.1016/j.ejphar.2022.174797. Epub 2022 Feb 3. Eur J Pharmacol. 2022. PMID: 35122867

10

Chlorin e6-Induced Photodynamic Effect Polarizes the Macrophage Into an M1 Phenotype Through Oxidative DNA Damage and Activation of STING.

Yu TT, Han N, Li LG, Peng XC, Li QR, Xu HZ, Wang XY, Yang ZY, Chen X, Wang MF, Li TF. Yu TT, et al. Among authors: li qr, li tf, li lg. Front Pharmacol. 2022 Mar 3;13:837784. doi: 10.3389/fphar.2022.837784. eCollection 2022. Front Pharmacol. 2022. PMID: 35308251 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

212 results

Search Page

Filters